Bioline Rx reported $-977K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
Bio Path USD -976K 3.62M Sep/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025